Promedior, a biotechnology company that focuses on anti-tissue-scarring therapies, has lined up the patients it needs for two Phase 2 studies of PRM-151, an anti-scarring agent it is evaluating for the treatment of idiopathic pulmonary fibrosis (IPF) and myelofibrosis. “We believe attaining these (patient) enrollment milestones speaks to both the…
In this video from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis shared in September 2014, Dr. Luca Richeldi from the Center for Rare Lung Diseases at the University of Modena and Reggio Emilia in Italy, talks about the progression of idiopathic pulmonary fibrosis (IPF) and the quality of life patients…
Differences in the expression of small RNAs, called microRNAs, which may be useful for identifying patients with idiopathic pulmonary fibrosis (IPF) at risk of an acute flare. The study, “Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis,” was published in the journal Diagnostic Pathology. An acute IPF…
I still remember the day my doctor diagnosed me with pulmonary fibrosis I was hit with a ton of emotions, all at once. I couldn’t believe what he was saying. I was confused, incredibly sad, angry and disoriented. I felt one emotion, then another and then a third…
In this short video from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis shared in September 2014, Dr. Toby Maher from the National Heart and Lung Institute at the Imperial College in the U.K. talks about how doctors discuss idiopathic pulmonary fibrosis (IPF) with their newly diagnosed patients. Discover seven reasons why…
Living with pulmonary fibrosis (PF) is difficult, both physically and emotionally. However, there are ways that you can manage your condition which will help you to improve your quality of life and reduce the stress associated with having a chronic illness. We’ve compiled a list of nine ways you can better…
In this video from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis shared in September 2014, Professor Vincent Cottin from the National Reference Center for Rare Pulmonary Diseases in Lyon, France talks about how difficult it is to diagnose idiopathic pulmonary fibrosis and how often it’s misdiagnosed. Find out more…
Typically speaking, I pride myself on consciously choosing not to express hatred toward anyone or anything. It is my personal belief that the word hate is overused in our society, and that it can have terribly negative effects on people overall, impacting the general mood, creating a toxic work place,…
The University of Alabama at Birmingham’s cystic fibrosis (CF) research center has chosen a Dutch company’s advanced X-ray CAT-scan system to help it conduct animal research in CF, pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), and sinonasal conditions. Utrecht-based MILabs’ U-CTUHR microCT system will provide researchers at the University…
In this short video from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis shared in September 2014, Professor Vincent Cottin from the Université Claude Bernard Lyon, France, talks about diseases which can often be confused with idiopathic pulmonary fibrosis. Find out about the importance of early diagnosis of pulmonary fibrosis. …
Get regular updates to your inbox.
